Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC
(MedPage Today) -- In patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed on a novel hormonal therapy, the combination of cabozantinib (Cabometyx) plus atezolizumab (Tecentriq) improved radiographic progression... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 22, 2024 Category: Hematology Source Type: news
Perceived vs Actual Cognitive Impairment in Prostate Cancer Perceived vs Actual Cognitive Impairment in Prostate Cancer
Following hormone therapy, patients with prostate cancer may perceive an increase in cognitive issues, despite tests showing no objective decline, a recent meta-analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Dr Phil slams US doctors for performing sex-change surgeries on hundreds of trans children a year during Joe Rogan podcast: 'It's a social contagion'
Dr Phil, America's controversial TV psychologist, slammed the medical community for rushing to put gender-confused kids on hormonal therapy or to have them undergo surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - February 21, 2024 Category: Consumer Health News Source Type: news
Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI
Men with metastatic castration-resistant prostate cancer had a slight but significant improvement in progression-free survival with a TKI plus immunotherapy vs hormonal therapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Cabozantinib Plus Atezolizumab Delays Progression in mCRPC
(MedPage Today) -- SAN FRANCISCO -- In patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed on a novel hormonal therapy, the combination of cabozantinib (Cabometyx) plus atezolizumab (Tecentriq) improved... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 27, 2024 Category: Hematology Source Type: news
Ohio bans transgender drugs and surgery for children under 18 and blocks trans kids from participating in girls' sports
The Ohio state legislature overrode the Governor's veto today, stopping doctors prescribing puberty blockers, hormone therapy and gender surgery to minors. (Source: the Mail online | Health)
Source: the Mail online | Health - January 24, 2024 Category: Consumer Health News Source Type: news
Menopause Is Finally Going Mainstream
Kathryn Clancy wrote an entire book about menstrual cycles. But even she was surprised by some of the pre-menopausal symptoms she recently began to experience at age 44.
“A lot of things that have to do with my uterus, ovaries, and breasts, I have been massively underprepared for as a Ph.D.-level expert in this field,” says Clancy, a professor at the University of Illinois Urbana-Champaign. “That should tell you how even more underprepared most people are.”
[time-brightcove not-tgx=”true”]
Most people who menstruate will experience symptoms including hot flashes, brain fog, and ch...
Source: TIME: Health - January 23, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Do Statins Offset Venous Thrombosis Risk With Hormone Therapy? Do Statins Offset Venous Thrombosis Risk With Hormone Therapy?
Statins might offer a way to reduce the risk for a potentially serious adverse effect of hormone therapy.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2024 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news
Receipt of Novel Hormonal Therapy for Advanced Prostate Cancer Varies With Race
THURSDAY, Dec. 28, 2023 -- For Medicare beneficiaries with advanced prostate cancer (PCa), receipt of novel hormonal therapy (NHT) agents varies with race, according to a study published online Dec. 1 in JAMA Network Open.
Ting Martin Ma, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2023 Category: Pharmaceuticals Source Type: news
New Insights Into Fibroids Might Lead to Better Treatments
THURSDAY, Dec. 28, 2023 -- Hormone therapy is the usual go-to when women develop painful uterine fibroids, but researchers report they are zeroing in on new avenues for treatment.A University of Cincinnati team found that fibroid cells respond to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 28, 2023 Category: General Medicine Source Type: news
Malpractice Insurance Prices Are Stopping Small Clinics From Offering Gender-Affirming Care to Minors
After Iowa lawmakers passed a ban on gender-affirming care for minors in March, managers of an LGBTQ+ health clinic located just across the state line in Moline, Illinois, decided to start offering that care.
The added services would provide care to patients who live in largely rural eastern Iowa, including some of the hundreds previously treated at a University of Iowa clinic, saving them half-day drives to clinics in larger cities like Chicago and Minneapolis.
[time-brightcove not-tgx=”true”]
By June, The Project of the Quad Cities, as the Illinois clinic is called, had hired a provider who specializes...
Source: TIME: Health - December 21, 2023 Category: Consumer Health News Authors: Cecilia Nowell Tags: Uncategorized LGBTQ Source Type: news
Sharp Uptick in Gender-Affirming Hormone Therapy Visits After ACA's Passage
(MedPage Today) -- Healthcare visits for transgender-related diagnoses and gender-affirming hormone therapy (GAHT) have been rising, researchers reported, suggesting it as an opportunity for HIV prevention.
Within a commercial health plan database... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - December 18, 2023 Category: Psychiatry Source Type: news
From drag bans to sports restrictions, 75 anti-LGBTQ bills have become law in 2023
Becky Hormuth and her transgender son, Levi, thought they were protected after a Missouri law banning transition-related care for minors took effect in August. The law grandfathered in those who had already been receiving puberty blockers or hormone therapy prior to Aug. 28, meaning they, in…#beckyhormuth #missouri #lesbian #aclu #lgbtq #williamsinstitute #levi #hormuths #florida #georgia (Source: Reuters: Health)
Source: Reuters: Health - December 17, 2023 Category: Consumer Health News Source Type: news
How Gender-Affirming Treatment Affects Erythrocytosis How Gender-Affirming Treatment Affects Erythrocytosis
Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - December 4, 2023 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news
Black Men With Advanced Prostate Cancer Lack Access to Best Treatments
MONDAY, Dec. 4, 2023 -- Black men diagnosed with advanced prostate cancer are significantly less likely to be prescribed hormone therapy that could extend their lives, compared to other racial and ethnic groups, a new study shows.
Studies have... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 4, 2023 Category: General Medicine Source Type: news
